Form 4: USANA Health Sciences Director Ding Xia Reports Stock Transactions
SEC Form 4 Filing
Director Ding Xia of USANA Health Sciences reports acquisition and disposal of common stock and restricted stock units.
Summary
- On August 2, 2024, Director Ding Xia of USANA Health Sciences reported transactions involving common stock and restricted stock units.
- 674 shares of common stock were acquired through the vesting of restricted stock units.
- 169 shares were disposed of to cover tax obligations at a price of $42.82 per share.
- Following these transactions, Ding Xia directly owns 3,028 shares of common stock and 2,023 restricted stock units.
Sentiment
Score: 6
Explanation: The sentiment is neutral. The filing reflects routine transactions related to stock-based compensation. There is no indication of unusual trading activity or concerns about the company's prospects.
Positives
- The vesting of restricted stock units indicates a positive performance milestone for the director.
- Continued direct ownership of 3,028 shares demonstrates ongoing investment in the company.
Negatives
- The disposal of 169 shares to cover tax obligations, while routine, slightly reduces the director's holdings.
Future Outlook
The remaining restricted stock units will vest in tranches on November 2, 2024, February 2, 2025, and May 2, 2025.
Industry Context
Form 4 filings are standard practice and provide transparency into the trading activities of company insiders, which can influence investor sentiment.
Stakeholder Impact
- The transactions provide transparency to shareholders regarding insider trading activity.
- The vesting of restricted stock units aligns the director's interests with those of the shareholders.
Key Dates
| Date | Description |
|---|---|
| 08/02/2024 | Date of stock transactions (acquisition and disposal) and vesting of restricted stock units. |
| 08/02/2024 | First vesting date of 25% of Restricted Stock Units. |
| 11/02/2024 | Second vesting date of 25% of Restricted Stock Units. |
| 02/02/2025 | Third vesting date of 25% of Restricted Stock Units. |
| 05/02/2025 | Fourth vesting date of 25% of Restricted Stock Units. |
| 08/05/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.